ACURA PHARMACEUTICALS, INC (ACUR)
Data as of , from SEC Form 4 filings.
See up to 3 months of ACUR. The 7-day demo opens the 1M and 3M ranges and puts ACUR on your watchlist.
Start 7-day demoLatest ACUR insider trades
Immanuel Thangaraj - DirectorOption exercise50,000 sh- Immanuel Thangaraj - DirectorOption exercise50,000 sh
- Immanuel Thangaraj
About ACURA PHARMACEUTICALS, INC (ACUR)
ACURA PHARMACEUTICALS, INC is an SEC registrant, filing under CIK 0000786947, classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
ACUR Form 4 activity by transaction type, last 90 days
No Form 4 activity for ACUR in the last 90 days.
ACUR insider transactions (Form 4)
93 Form 4 filings on record, the earliest from Jan 15, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Immanuel Thangaraj - Director | Option exercise | Common Stock | 50,000 | - footnote F2 | - | |
| Immanuel Thangaraj - Director | Option exercise | Restricted Stock Units (2021 Plan) | 50,000 | - footnote F6 | - | |
| Immanuel Thangaraj - Director | Grant or award | Restricted Stock Units (2021 Plan) | 50,000 | - footnote F6 | - | |
| ||||||
| William G. Skelly - Director | Option exercise | Common Stock | 50,000 | - footnote F2 | - | |
| William G. Skelly - Director | Option exercise | Restricted Stock Units (2021 Plan) | 50,000 | - footnote F6 | - | |
| William G. Skelly - Director | Grant or award | Restricted Stock Units (2021 Plan) | 50,000 | - footnote F6 | - | |
| ||||||
| George K. Ross - Director | Option exercise | Common Stock | 50,000 | - footnote F2 | - | |
| George K. Ross - Director | Option exercise | Restricted Stock Units (2021 Plan) | 50,000 | - footnote F6 | - | |
| George K. Ross - Director | Grant or award | Restricted Stock Units (2021 Plan) | 50,000 | - footnote F6 | - | |
| ||||||
ACUR insider trading FAQ
What is the latest insider trade for ACUR?
ACURA PHARMACEUTICALS, INC (ACUR) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-01-15. The full record for ACUR runs to 3 Form 4 filings, the earliest from 2026-01-15. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ACUR stock?
No insider purchases of ACUR were filed in the last 90 days.
How many insiders are selling ACUR stock?
No insider sales of ACUR were filed in the last 90 days.
Where can I see ACUR SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ACUR Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
3The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Immanuel Thangaraj view on EDGAR
- - William G. Skelly view on EDGAR
- - George K. Ross view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where ACUR's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ACUR with a 7-day demo
- ACUR on your watchlist
- Every ACUR Form 4 filing on record
- Up to 3 months of ACUR price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
